I am delighted to announce that *Bone & Joint Research* (BJR), which was only established in 2012, has now received its first impact factor, which is 1.640. This is the first opportunity that the BJR has had to get an impact factor, as a journal must be registered in PubMed for at least three years. The journal impact factor is an independent measure calculated by Thomson Reuters in Philadelphia, United States and only a subset of journals are considered to be of sufficient quality to be listed by Thomson Reuters for an impact factor. The impact factors range from under 1 to over 50 (e.g. *New England Journal of Medicine* 55.87). Unfortunately, orthopaedic journals have relatively low impact factors, which tend to be less than 5.

In comparison, several other body systems have journals with far higher impact factors, for example, the neurological system (e.g. *Nat Rev Neurosci*31.4, *Annu Rev Neurosci* 22.7, *Trends Cogn Sci* 21.1, *Neuron* 16) and the cardiovascular system (e.g. *J Am Coll Cardiol* 15.3, *Circulation* 14.9, *Eur Heart J* 14.7, *Circ Res* 11.1) have multiple journals with high impact factors. It is, therefore, worth reflecting as to why orthopaedic journals do not have higher impact factors.

The impact factor for a journal in a given year is calculated by dividing the number of citations, in that year, to the source items published in that journal during the previous two years, by the number of citable articles in the preceding two years. For example, the journal impact factor for Year X = (Year X citations to Year (X-1) + Year (X-2) articles)/(no. of \"citable\" articles published in Year (X-1) + Year (X-2)). Thus, for a citation to count towards a journal's impact factor, it needs to be cited within two years of publication.

There are a number of factors that affect the total number of citations. The citations can be distributed evenly between the articles published, or, they can be heavily weighted to a small number of articles, which have a very high number of citations. For instance, in 2005 a study in *Nature* reported that 89% of the citations in its journal came from only 25% of the articles published.^[@r1]^ Haddad^[@r2]^ has listed a number of other factors that affect the number of citations, which include the number of publications in a research field; the average number of references in a paper and the type of article -- reviews tend to get more citations, and scientific articles tend only to cite scientific articles, whereas clinical papers cite both clinical and preclinical articles. In addition to these factors, the citation rate is also dependent upon the number of researchers in a given field; the country of origin; the country where it is published and the language in which it is written.

Furthermore, as the impact factor does not count all citations a paper has received, but only those in the preceding two years, the vast majority of research that will quote a paper in that time period will already have been started before the cited paper is published. This makes the impact factor even more dependent on the number of researchers in a given field. Kodumuri et al^[@r3]^ have also pointed out the critical nature of the time period over which the citations are considered, as there is a greater lag time for surgical papers to be cited.

Demonstration of the impact of research is gaining increasing importance worldwide, as national funding bodies are using this to determine the allocation of central funding. Publications in journals with high impact factors are often used as a mark of this. However, different types of papers have different target audiences. For some, the paper is aimed at researchers, for others it is clinicians and for others still, policy makers. These different 'audiences' have different rates of citation, thus, a paper that has a message which is most relevant to practicing clinicians who do not write papers, may have a lower citation rate than a paper whose target readership is academics who, themselves, write regularly. There will be exceptions to this, such as the pivotal randomised controlled trials (RCTs), which will be read by clinicians and quoted by academics. As a consequence of this, the relationship between downloads (marker of use by clinicians, researchers and policy makers) and citations (marker of use by researchers) will not necessarily be linear. In 2014, the five most cited BJR papers^[@r4]-[@r8]^ from 2013 are listed in Table I and the five most downloaded BJR papers^[@r8]-[@r12]^ are listed in Table II. Only one paper is in both Tables (Fig. 1). As might be expected, the highly cited papers in Table I are more relevant to researchers. The highly downloaded papers were on clinical update topics that would be expected to appeal more to practicing clinicians. Although not cited greatly, the high downloads indicate that these papers appear to have had a significant impact on clinical practice.
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###### 

Most highly cited *Bone & Joint Research* papers published in 2013

  **Papers**                           **Citations (2014)**   **Downloads (2014)**
  ------------------------------------ ---------------------- ----------------------
                                                              
  Sidaginamale et al^[@r4]^ (P1)       8                      730
  Rodrigues-Pinto et al^[@r5]\ (P2)^   7                      1042
  Kon et al^[@r6](P3)^                 7                      962
  Goffin et al^[@r7]^ (P4)             4                      812
  Patel et a^[@r8]^ (P5)               4                      1139

###### 

Most highly downloaded*Bone & Joint Research* papers published in 2013

  **Papers**                    **Citations (2014)**   **Downloads (2014)**
  ----------------------------- ---------------------- ----------------------
                                                       
  Zhang et al^[@r9]^ (P9)       1                      16 659
  Karlakki et al^[@r10]^ (P8)   3                      2200
  Ketola et al^[@r11]^ (P7)     1                      1720
  Johnson et al^[@r12]^ (P6)    1                      1681
  Patel et al^[@r8]^ (P5)       4                      1139

A similar picture is seen with the orthopaedic clinical journal, *The Bone & Joint Journal*(BJJ; formerly JBJS-Br). Only one of the five most highly cited papers^[@r13]-[@r17]^ in the BJJ (Table III) and the five most highly downloaded papers^[@r15],[@r18]-[@r21]^ (Table IV) overlap.

###### 

Most highly cited papers in*The Bone & Joint Journal* published in 2013

  **Papers**                        **Citations (2014)**   **Downloads (2014)**
  --------------------------------- ---------------------- ----------------------
                                                           
  Jenkins et al^[@r13]^             19                     1010
  Chareancholvanich et al^[@r14]^   18                     776
  Parvizi et al^[@r15]^             16                     1072
  Zywiel et al^[@r16]^              13                     478
  Gøthesen et al^[@r17]^            13                     418

###### 

Most highly downloaded papers in *The Bone & Joint Journal* published in 2013

  **Papers**                 **Citations (2014)**   **Downloads (2014)**
  -------------------------- ---------------------- ----------------------
  Ahmad et al^[@r18]^        3                      2860
  Roche and Calder^[@r19]^   1                      2802
  Ibrahim et al^[@r20]^      1                      1411
  Modi et al^[@r21]^         1                      1084
  Parvizi et al^[@r15]^      16                     1072

Sarli et al^[@r22]^ have also recognised that the value of publications falls into different domains; research impact, knowledge transfer, clinical implementation and community benefit. They indicate that citation analysis alone, therefore, does not assess the impact of a paper fully. For this reason, several authors have examined alternative metrics of research impact. For example, Brueton et al^[@r23]^ examined other ways of assessing the value of methodological research, such as the applications of a piece of work, further developments of the research, release of software and provision of guidance materials to facilitate uptake, formation of new collaborations, and broad dissemination.

Despite these concerns, the impact factor is a yardstick of a journal and an indication of quality of the review process; this is vitally important given the burgeoning number of open access journals, which do not always have the same pedigree of peer review.
